OBJECTIVES: This study investigates and compares the functioning and well-being of patients using long-acting injectable antipsychotics either voluntarily or under the direction of a CTO. METHODS: Patients from both groups (CTO or voluntary) completed a questionnaire with the assistance of the researcher. The questionnaire contained the Subjective Wellbeing Under Neuroleptics Scale (SW N) and the WHO Disability Assessment Schedule 2.0 (WHO-DAS). The researcher completed the Personal and Social Performance Scale (PSP) and the Health of the Nation Outcome Scale (HoNOS). RESULTS: Forty-one patients participated in this study of whom 22 participants were on a CTO mandating the use of an LAI-AP and 19 participants voluntarily used an LAI-AP. The results of a MANOVA indicated that there was no
significant difference between the two groups on the combination of the psychosocial outcome variables; F ( 4, 36) = .264, p = .899. CONCLUSIONS: The results indicate that there is no difference between the levels of psychosocial functioning between the two groups. This is contrary to expectations as it would be assumed that patients who are voluntarily involved in their own treatment would have superior psychosocial outcomes compared to those who require legislated care.